This paper critically evaluates a 2016 research article by Qiu et al. examining how cigarette smoking affects both adaptive and innate immunity. The review covers smoking's influence on key immune cell types — including T helper cells, CD8+ T cells, B cells, regulatory T cells, and innate cells such as macrophages and NK cells — and assesses whether the article successfully establishes causal links between smoking-related immune disruption and chronic diseases such as Crohn's disease, COPD, and autoimmune conditions. The critique highlights the article's strengths in contextualizing the global scale of tobacco use and its limitations in providing definitive mechanistic explanations for disease progression.
The 2016 article under review concerns cigarette smoking, its potential connections with disease, and its impact on the international healthcare system. The researchers argue that smoking affects both adaptive and innate immunity, playing a dual role in immune regulation by either attenuating defensive immunity or driving pathogenic immune responses. The adaptive immune cells affected by cigarette smoking include "T helper cells (Th1/Th2/Th17), CD4+CD25+ regulatory T cells, CD8+ T cells, B cells and memory T/B lymphocytes, while innate immune cells impacted by smoking are mostly DCs, macrophages and NK cells" (Qiu et al., 2015, p. 1). The changes in these cells due to smoking can contribute to numerous chronic or acute conditions, including autoimmune diseases, cancers, transplant rejection, respiratory and cardiovascular diseases, and allergies.
The researchers note that past studies connect smoking with specific diseases such as lung cancer and emphysema; however, sufficiently updated reviews examining smoking's impact on general immunity are lacking. Furthermore, little research exists on smoking's influence on the major components of immune cells. The aim of the article is to objectively and systematically review cigarette smoking's influence on key components of adaptive and innate immune cells, and to summarize the molecular and cellular mechanisms underlying those effects.
The researchers found that the molecular pathways affected by cigarette smoking involve histone modification and MAP and NFκB kinases. They conclude with a statement calling for further examination of the true impact cigarette smoking has on smoking-mediated immunopathology. Although smoking has a dual effect on a person's immune responses, the overall effect is negative. Therefore, more investigation into the specific negative impacts may produce a distinct causal link to diseases that exist today, such as multiple sclerosis or other immune-related illnesses.
Although the paper does a commendable job of explaining potential causes of some diseases related to cigarette smoking, no definitive link is established. This is notable given the extensive body of research on cigarette smoking and its adverse health effects. One aspect that strengthens the review's legitimacy is its description of the global prevalence of tobacco use: with roughly one-third of the world's population smoking, the scale of the problem is significant. By detailing what cigarettes contain — including nicotine and cadmium — the article effectively frames tobacco as a dangerous substance. This context is well executed within the first paragraph of the introduction.
Returning to the question of specificity, the article does not identify a clear cause of disease; rather, it describes an effect of cigarette smoking on allograft survival via costimulatory blockade. Table 1, which was intended to show which diseases are caused by cigarette smoking, only lists their names without explaining why smoking causes them. This is where the review lacks both breadth and depth. If the purpose of the article is to show smoking's general impact on immunity, it should also demonstrate the potential impact on specific illnesses such as lupus or rheumatoid arthritis. This omission represents the article's main weakness. Following Table 1, the article moves somewhat haphazardly into the effects of cigarette smoking on adaptive immunity.
"Contradictory evidence on T cell and CD8+ effects"
"Genetic background moderates smoking's immune impact"
In conclusion, while the article was thorough in describing the effects of cigarette smoking on immune cells, it failed to create a clear connection between disease progression and smoking.
You’re 55% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.